TABLE OF CONTENTS
1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.3 OVERVIEW OF EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET 42
1.4 LIMITATIONS 44
1.5 MARKETS COVERED 44
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 CURRENCY AND PRICING 49
2.5 DBMR TRIPOD DATA VALIDATION MODEL 50
2.6 MULTIVARIATE MODELLING 53
2.7 PRODUCT LIFELINE CURVE 53
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.9 DBMR MARKET POSITION GRID 55
2.10 MARKET END USERS COVERAGE GRID 56
2.11 VENDOR SHARE ANALYSIS 57
2.12 SECONDARY SOURCES 58
2.13 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 61
4.1 VALUE CHAIN ANALYSIS 62
4.2 SUPPLY CHAIN ANALYSIS 63
4.2.1 RAW MATERIAL PROCUREMENT 63
4.2.2 MANUFACTURING AND DISTRIBUTION 63
4.2.3 END USERS 63
4.3 PORTER'S FIVE FORCES 64
4.3.1 BARGAINING POWER OF SUPPLIERS 64
4.3.2 BARGAINING POWER OF BUYERS/CONSUMERS 64
4.3.3 THREAT OF NEW ENTRANTS 65
4.3.4 THREAT OF SUBSTITUTES PRODUCTS 65
4.3.5 INTENSITY OF COMPETITIVE RIVALRY 65
4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 66
4.5 OVERVIEW OF TECHNOLOGICAL INNOVATIONS 67
4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 68
4.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS 69
5 PRICING ANALYSIS 70
6 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET, REGULATIONS 71
7 MARKET OVERVIEW, EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET 73
7.1 DRIVERS 75
7.1.1 GROWING PRODUCTION OF FEED ADDITIVES 75
7.1.2 INCREASING AWARENESS OF THE BENEFITS OF PLANT-BASED PRODUCTS 75
7.1.3 INCREASED DEMAND AND CONSUMPTION OF LIVESTOCK-BASED PRODUCTS 76
7.2 RESTRAINTS 76
7.2.1 STRICT RESTRICTIONS AND REGULATIONS IMPOSED BY GOVERNMENT 76
7.2.2 INADEQUATE RAW MATERIAL AVAILABILITY 77
7.3 OPPORTUNITIES 77
7.3.1 GROWING COMMERCIAL APPLICATION 77
7.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 77
7.4 CHALLENGES 78
7.4.1 AVAILABILITY OF FEED ADDITIVE SUBSTITUTES 78
7.4.2 PRODUCT LABELLING AND TRADE ISSUES 78
8 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET, BY PRODUCT 79
8.1 OVERVIEW 80
8.1.1 BACTERIA BASED 83
8.1.1.1 BACILLUS 84
8.1.1.1.1 SUBTILIS 85
8.1.1.1.2 LICHENIFORMIS 85
8.1.1.1.3 AMYLOLIQUEFACIENS 85
8.1.1.1.4 MEGATERIUM 85
8.1.1.1.5 MESENTRICUS 85
8.1.1.1.6 POLYMYXA 85
8.1.1.1.7 TOYONENSIS 85
8.1.1.1.8 OTHERS 85
8.1.1.2 LACTOBACILLUS 86
8.1.1.2.1 ACIDOPHILUS 86
8.1.1.2.2 BULGARICUS 86
8.1.1.2.3 REUTERI 86
8.1.1.2.4 CASEI 87
8.1.1.2.5 LACTIS 87
8.1.1.2.6 SALIVARIUS 87
8.1.1.2.7 PLANTARUM 87
8.1.1.2.8 RHAMNOSUS 87
8.1.1.2.9 FERMENTUM 87
8.1.1.2.10 FARCIMINIS 87
8.1.1.2.11 THERMOPHILUS 87
8.1.1.2.12 OTHERS 88
8.1.1.3 BIFIDOBACTERIUM 88
8.1.1.3.1 BIFIDIUM 88
8.1.1.3.2 BIFIDUS 88
8.1.1.3.3 THERMOPHILUS 88
8.1.1.3.4 ANIMALS 88
8.1.1.3.5 OTHERS 89
8.1.1.4 ENTEROCOCCUS 89
8.1.1.5 STREPTOCOCCUS 89
8.1.1.6 CLOSTRIDIUM 89
8.1.1.7 PEDIOCOCCUS 89
8.1.1.7.1 PARVULUS 89
8.1.1.7.2 ACIDILACTICI 89
8.1.1.7.3 OTHERS 90
8.1.2 FUNGI AND YEAST BASED 90
8.1.2.1 SACCHAROMYCES CEREVISIAE 91
8.1.2.2 SACCHAROMYCES BOULARDII 91
8.1.2.3 SACCHAROMYCES SERVISIA 91
8.1.2.4 CANDIDA 91
9 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET, BY TYPE 92
9.1 OVERVIEW 93
9.1.1 SINGLE STRAIN 96
9.1.2 MULTIPLE STRAIN 96
10 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET, BY FORM 98
10.1 OVERVIEW 99
10.1.1 DRY 102
10.1.2 LIQUID 102
11 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET, BY FUNCTION 104
11.1 OVERVIEW 105
11.1.1 GUT HEALTH 108
11.1.2 IMMUNITY 108
11.1.3 NUTRITION 109
11.1.4 FEED INTAKE AND EFFICIENCY 110
11.1.5 YIELD 110
11.1.6 EGG PRODUCTION AND QUALITY 111
11.1.7 OTHERS 112
12 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 113
12.1 OVERVIEW 114
12.1.1 CHICKS AND POULTS 117
12.1.1.1 BACTERIA BASED 118
12.1.1.2 FUNGI AND YEAST BASED 118
12.1.2 BROILERS 118
12.1.2.1 BACTERIA BASED 119
12.1.2.2 FUNGI AND YEAST BASED 119
12.1.3 LAYERS 119
12.1.3.1 BACTERIA BASED 120
12.1.3.2 FUNGI AND YEAST BASED 120
12.1.4 BREEDERS 120
12.1.4.1 BACTERIA BASED 121
12.1.4.2 FUNGI AND YEAST BASED 121
12.1.5 OTHERS 121
13 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET, BY REGION 122
13.1 EUROPE 123
13.1.1 GERMANY 132
13.1.2 RUSSIA 137
13.1.3 TURKEY 141
13.1.4 ITALY 145
13.1.5 U.K. 149
13.1.6 FRANCE 153
13.1.7 POLAND 157
13.1.8 SPAIN 161
13.1.9 SWITZERLAND 165
13.1.10 NETHERLANDS 169
13.1.11 BELGIUM 173
13.1.12 DENMARK 177
13.1.13 SWEDEN 181
13.1.14 REST OF EUROPE 185
14 EUROPE POULTRY PROBIOTIC INGREDIENTS MARKET: COMPANY LANDSCAPE 186
14.1 COMPANY SHARE ANALYSIS: EUROPE 186
15 SWOT ANALYSIS 187
16 COMPANY PROFILE 188
16.1 LALLEMAND INC 188
16.1.1 COMPANY SNAPSHOT 188
16.1.2 COMPANY SHARE ANALYSIS 188
16.1.3 PRODUCT PORTFOLIO 189
16.1.4 RECENT DEVELOPMENT 189
16.2 EVONIK INDUSTRIES AG 190
16.2.1 COMPANY SNAPSHOT 190
16.2.2 REVENUE ANALYSIS 190
16.2.3 COMPANY SHARE ANALYSIS 191
16.2.4 PRODUCT PORTFOLIO 191
16.2.5 RECENT DEVELOPMENT 191
16.3 ASAHI GROUP HOLDINGS, LTD 192
16.3.1 COMPANY SNAPSHOT 192
16.3.2 REVENUE ANALYSIS 192
16.3.3 COMPANY SHARE ANALYSIS 193
16.3.4 PRODUCT PORTFOLIO 193
16.3.5 RECENT DEVELOPMENT 193
16.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 194
16.4.1 COMPANY SNAPSHOT 194
16.4.2 REVENUE ANALYSIS 194
16.4.3 COMPANY SHARE ANALYSIS 195
16.4.4 PRODUCT PORTFOLIO 195
16.4.5 RECENT DEVELOPMENT 195
16.5 PHILEO BY LESAFFRE 196
16.5.1 COMPANY SNAPSHOT 196
16.5.2 COMPANY SHARE ANALYSIS 196
16.5.3 PRODUCT PORTFOLIO 197
16.5.4 RECENT DEVELOPMENT 197
16.6 ADVANCED ENZYME TECHNOLOGIES 198
16.6.1 COMPANY SNAPSHOT 198
16.6.2 REVENUE ANALYSIS 198
16.6.3 PRODUCT PORTFOLIO 199
16.6.4 RECENT DEVELOPMENT 199
16.7 ALLTECH 200
16.7.1 COMPANY SNAPSHOT 200
16.7.2 PRODUCT PORTFOLIO 200
16.7.3 RECENT DEVELOPMENTS 200
16.8 BIOCAMP 201
16.8.1 COMPANY SNAPSHOT 201
16.8.2 PRODUCT PORTFOLIO 201
16.8.3 RECENT DEVELOPMENT 201
16.9 CHR. HANSEN HOLDING A/S 202
16.9.1 COMPANY SNAPSHOT 202
16.9.2 REVENUE ANALYSIS 202
16.9.3 PRODUCT PORTFOLIO 203
16.9.4 RECENT DEVELOPMENT 203
16.10 INTERNATIONAL ANIMAL HEALTH PRODUCTS 204
16.10.1 COMPANY SNAPSHOT 204
16.10.2 PRODUCT PORTFOLIO 204
16.10.3 RECENT DEVELOPMENT 204
16.11 KEMIN INDUSTRIES, INC 205
16.11.1 COMPANY SNAPSHOT 205
16.11.2 PRODUCT PORTFOLIO 205
16.11.3 RECENT DEVELOPMENT 205
16.12 NOVOZYMES 206
16.12.1 COMPANY SNAPSHOT 206
16.12.2 REVENUE ANALYSIS 206
16.12.3 PRODUCT PORTFOLIO 207
16.12.4 RECENT DEVELOPMENT 207
16.13 PANGOO 208
16.13.1 COMPANY SNAPSHOT 208
16.13.2 PRODUCT PORTFOLIO 208
16.13.3 RECENT DEVELOPMENT 208
16.14 PROVITA ANIMAL HEALTH 209
16.14.1 COMPANY SNAPSHOT 209
16.14.2 PRODUCT PORTFOLIO 209
16.14.3 RECENT DEVELOPMENT 209
16.15 UNIQUE BIOTECH 210
16.15.1 COMPANY SNAPSHOT 210
16.15.2 PRODUCT PORTFOLIO 210
16.15.3 RECENT DEVELOPMENT 210
17 QUESTIONNAIRE 211
18 RELATED REPORTS 214

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.